Experimental Vaccine to Prevent Fentanyl Overdose Enters Human Trials
An experimental “anti-fentanyl” vaccine developed by ARMR Sciences, Inc. of New York and the University of Houston has entered Phase 1/2 human trials, according to a June 17 press release issued by the company. The vaccine candidate has spent years in development and vaccine developers say it represents a potential intervention in America’s ongoing overdose […]